先看重點
在291名60歲及以上的失眠成年人中,為期2個月的失眠認知行為療法(CBT-I)使新發或復發重性憂鬱的比例由睡眠教育療法組的25.9%降至12.2%(風險比0.51,95%置信區間0.29-0.88,P = .02)。試驗僅在單中心進行,CBT-I組的追蹤完成率較低(24個月時73.1%對86.7%)。
證據類型
隨機對照試驗
解讀依據
公開摘要
閱讀重點
對照與不確定性
研究在問什麼
患有失眠的老年人新發和復發憂鬱的風險很高,但這一年齡段的憂鬱預防一直被忽視。作者檢驗了用CBT-I治療失眠障礙,與積極對照的睡眠教育療法(SET)相比,是否更能預防重性憂鬱障礙。
研究對象與方法
評估者設盲、平行組、單中心隨機臨床試驗。在社群評估的431人中,2012年7月1日至2015年4月30日納入291名60歲及以上、患有失眠障礙且過去一年無重性憂鬱或重大健康事件的成年人。他們被隨機分到2個月的CBT-I(n = 156)或SET(n = 135)。主要結局是透過訪談和DSM-5標準診斷的重性憂鬱障礙發生時間,次要結局是失眠持續緩解。追蹤由24個月延長至36個月,於2018年7月結束。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1CBT-I組有19人(12.2%)、SET組有35人(25.9%)發生新發或復發重性憂鬱(風險比0.51,95%置信區間0.29-0.88,P = .02),各亞組獲益一致。
- 2在憂鬱事件發生前或追蹤期間持續緩解失眠的比例,CBT-I組更高(41人,26.3%),SET組為26人(19.3%,P = .03)。
- 3CBT-I組中失眠持續緩解者,與SET組中未持續緩解者相比,憂鬱可能性降低82.6%(風險比0.17,95%置信區間0.04-0.73,P = .02)。
- 4完成CBT-I的人數(140人,89.7%)少於SET(130人,96.3%,P = .03),24個月追蹤完成者分別為114人(73.1%)和117人(86.7%)(P = .004);36個月時為81人(51.9%)和77人(57.0%)(P = .39)。
限制與不確定性
- 1許多參與者未完成36個月追蹤(CBT-I組81人,SET組77人),且延長追蹤是在方案開始後增加的,較晚期的結果不確定性更大。
- 2失訪不均衡,24個月時CBT-I組退出者更多,可能使比較產生偏倚。
- 3試驗僅在單箇中心進行,樣本中82.8%為白人,結果未必適用於其他族群或醫療體系。
- 4持續緩解與未緩解的比較不是隨機比較,且置信區間較寬(0.04-0.73)。本解讀僅基於摘要。
日常健康啟示
對患有失眠的老年人,短程CBT-I在治療睡眠之外似乎還有助於預防憂鬱,這支援在心理健康照護中詢問睡眠情況。這並不是停止其他治療的理由,情緒低落或失眠持續者應諮詢臨床醫師,由其提供CBT-I或類似支援。
如何連結自己的資料
睡眠追蹤器記錄的睡眠時長、就寢時間規律和夜間醒來次數,可以補充CBT-I中使用的睡眠日記,但裝置上睡眠差的夜晚並不能檢測憂鬱。請使用同一裝置,重點觀察數週的睡眠規律趨勢,最好同時記睡眠日記。
如何理解這類證據
隨機分組有助於因果推斷,仍須檢查分配、盲法、失去追蹤、追蹤時間和具體對照;標為隨機試驗不自動意味著高確定性。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Importance
Older adults with insomnia have a high risk of incident and recurrent depression. Depression prevention is urgently needed, and such efforts have been neglected for older adults.
Objective
To examine whether treatment of insomnia disorder with cognitive behavioral therapy for insomnia (CBT-I) compared with an active comparator condition, sleep education therapy (SET), prevents major depressive disorder in older adults.
Design, setting, and participants
This assessor-blinded, parallel-group, single-site randomized clinical trial assessed a community-based sample of 431 people and enrolled 291 adults 60 years or older with insomnia disorder who had no major depression or major health events in past year. Study recruitment was performed from July 1, 2012, to April 30, 2015. The trial protocol was modified to extend follow-up from 24 to 36 months, with follow-up completion in July 2018. Data analysis was performed from March 1, 2019, to March 30, 2020.
Interventions
Participants were randomized to 2 months of CBT-I (n = 156) or SET (n = 135).
Main outcomes and measures
The primary outcome was time to incident major depressive disorder as diagnosed by interview and Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) criteria. Secondary outcome was sustained remission of insomnia disorder before depression event or duration of follow-up.
Results
Among 291 randomized participants (mean [SD] age, 70.1 [6.7] years; 168 [57.7%] female; 7 [2.4%] Asian, 32 [11.0%] Black, 3 [1.0%] Pacific Islander, 241 [82.8%] White, 6 [2.1%] multiracial, and 2 [0.7%] unknown), 156 were randomized to CBT-I and 135 to SET. A total of 140 participants (89.7%) completed CBT-I and 130 (96.3%) participants completed SET (χ2 = 4.9, P = .03), with 114 (73.1%) completing 24 months of follow-up in the CBT-I group and 117 (86.7%) in the SET group (χ2 = 8.4, P = .004). After protocol modification, 92 (59.0%) of the CBT-I participants and 86 (63.7%) of the SET participants agreed to extended follow-up (χ2 = 0.7, P = .41), with 81 (51.9%) of the CBT-I participants and 77 (57.0%) of the SET group completing 36 months of follow-up (χ2 = 0.8; P = .39). Incident or recurrent major depression occurred in 19 participants (12.2%) in the CBT-I group and in 35 participants (25.9%) in the SET group, with an overall benefit (hazard ratio, 0.51; 95%, CI 0.29-0.88; P = .02) consistent across subgroups. Remission of insomnia disorder continuously sustained before depression event or during follow-up was more likely in CBT-I participants (41 [26.3%]) compared with the SET participants (26 [19.3%], P = .03). Those in the CBT-I group with sustained remission of insomnia disorder had an 82.6% decreased likelihood of depression (hazard ratio, 0.17; 95%, CI 0.04-0.73; P = .02) compared with those in the SET group without sustained remission of insomnia disorder.
Conclusions and relevance
The findings of this randomized clinical trial indicate that treatment of insomnia with CBT-I has an overall benefit in the prevention of incident and recurrent major depression in older adults with insomnia disorder. Community-level screening for insomnia concerns in older adults and wide delivery of CBT-I-based treatment for insomnia could substantially advance public health efforts to treat insomnia and prevent depression in this vulnerable older adult population.
Trial registration
ClinicalTrials.gov Identifier: NCT01641263.
來源與署名
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia: A Randomized Clinical Trial.
Irwin MR, Carrillo C, Sadeghi N, Bjurstrom MF, Breen EC, Olmstead R.
JAMA psychiatry · 2022-01-01
DOI: 10.1001/jamapsychiatry.2021.3422 ↗PubMed · 34817561 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
運動改善45歲及以上睡眠障礙者的睡眠質量評分
彙總23項隨機對照試驗、共1,478名45至77歲睡眠障礙成年人的資料,運動改善了匹茲堡睡眠質量指數評分(SMD 0.62,95%置信區間0.40–0.83),網路分析中有氧運動效果最大(SMD 1.34,95%可信區間0.86–1.82)。證據確定性為低到中等,結局是問卷評分,每週約539 MET-min的最佳劑量是模型估計值,不是處方。
Journal of Exercise Science & Fitness
睡眠規律性比睡眠時長更能預測英國成年人的死亡風險
在60,977名佩戴腕式加速度計一週的英國生物樣本庫成年人中,睡眠最規律的五分之一族群,經完全校正後的全因死亡風險比為0.70(95%置信區間0.59–0.83),對照為最不規律的五分之一,追蹤約6.3年,共1859人死亡。規律性對資料的擬合優於睡眠時長,但這是隻依據一週資料的觀察性研究。
Sleep
延長睡眠使超重成年人每日能量攝取減少約270千卡
在80名平時睡眠不足6.5小時的超重成年人中,兩週的延長睡眠指導使睡眠增加約1.2小時,實測能量攝取比對照組少270.4千卡/天(95%置信區間−393.4至−147.4)。這是一項為期短、單中心、族群較窄的試驗,不能說明體重會持續下降,也不能說明對睡眠本就充足的人有益。
JAMA Internal Medicine
50歲和60歲時每晚睡6小時及以下,與日後失智風險較高相關
在7959名英國公務員中追蹤約25年,50歲時每晚睡6小時及以下者的失智風險比為1.22(95%置信區間1.01–1.48),60歲時為1.37(1.10–1.72),均高於睡7小時者;長期持續睡眠偏短者為1.30(1.00–1.69)。睡眠主要靠自報,且為觀察性研究,早期腦部病變等因素可能解釋了部分關聯。
Nature Communications

